Main container

“Randomized, Controlled, Open-label, Phase IIb/III Study of Lurbinectedin in Combination with Doxorubicin versus Doxorubicin Alone as First-line Treatment in Patients with Metastatic Leiomyosarcoma

Titolo
“Randomized, Controlled, Open-label, Phase IIb/III Study of Lurbinectedin in Combination with Doxorubicin versus Doxorubicin Alone as First-line Treatment in Patients with Metastatic Leiomyosarcoma
Codice
PM1183-C-010-22
Tipo
Sperimentale con farmaco
Anno avvio
2024
Stato
In Corso

Sperimentatore principale

Unità operative che promuovono lo studio

Documenti e video allegati

Ti potrebbe interessare anche

Studi clinici
A Multi-Centre Clinical Investigation To Evaluate The Safety And Performance Of The Freedom Total Knee® System With The PEEK-OPTIMA™ Femoral Component
Leggi tutto
Studi clinici
Pediatric Oncological Orthopaedic Reconstructions: analysis of the clinical and radiographic results
Leggi tutto
Studi clinici
Clinical Outcomes of Patients Treated with Proximal Tibia Reconstruction - Esiti clinici dei pazienti sottoposti a ricostruzione della tibia prossimale
Leggi tutto